Abstract
An increased incidence of non-Hodgkin's lymphoma has been reported in patients with inflammatory bowel disease, particularly in those receiving immunosuppressive therapy. Rare cases of Hodgkin's lymphoma have been reported in a setting of inflammatory bowel disease. The mechanism underlying the apparent association is unclear, but alterations in immune surveillance could play a role. In this report we describe the clinicopathological features of primary gastrointestinal Hodgkin's lymphoma diagnosed in a patient with Crohn's ileocolitis who had been receiving therapy with immunomodulator and biologic therapies.
Original language | English (US) |
---|---|
Pages (from-to) | 359-361 |
Number of pages | 3 |
Journal | Journal of Gastrointestinal and Liver Diseases |
Volume | 18 |
Issue number | 3 |
State | Published - Dec 1 2009 |
Keywords
- Anti-TNF therapy
- Crohn's disease
- Hodgkin's lymphoma
- Immunomodulators
ASJC Scopus subject areas
- Gastroenterology